Juhui J. Jiao

Statistics

Publications

Citations

208

H-Index

Active since

2012

Affiliations

Janssen (United States)(Current)

Janssen (Belgium)

BC Cancer Agency

South Texas Accelerated Research Therapeutics

Juhui J. Jiao is an author at Janssen (United States) specializing in pharmacology, metastatic castration-resistant prostate cancer, and pharmacokinetics.

Publications per year

2012–2020

Publications

The effect of food on the pharmacokinetics of oral ibrutinib in healthy participants and patients with chronic lymphocytic leukemia

Jan de Jong, Juthamas Sukbuntherng, Donna Skee et al. · Cancer Chemotherapy and Pharmacology · 2015 · 78 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Open-label, phase I, pharmacokinetic studies of abiraterone acetate in healthy men

Milin Acharya, Apexa Bernard, Martha Gonzalez et al. · Cancer Chemotherapy and Pharmacology · 2012 · 48 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Effect of abiraterone acetate plus prednisone on the QT interval in patients with metastatic castration-resistant prostate cancer

Anthony W. Tolcher, K. N., Neal D. Shore et al. · Cancer Chemotherapy and Pharmacology · 2012 · 34 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate cancer

K. N., Anthony W. Tolcher, Peter P. Lee et al. · Cancer Chemotherapy and Pharmacology · 2012 · 34 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Pharmacokinetics, Safety, and Antitumor Effect of Apalutamide with Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer: Phase Ib Study

Edwin M. Posadas, Kim N., Ronald de Wit et al. · Clinical Cancer Research · 2020 · 14 citations

Medicine, Oncology, Pharmacology +17

1–5 of 5